Loading…
Reported covered position: Staff Assistant, Office of Rep. John Larson; Scheduler and Executive Assistant, Office of Rep. John Larson
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2026 · third_quarter · Q3
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
National Defense Authorization Act for Fiscal Year 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
Providing for consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (H.R. 8595) making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 8884) to amend title II of the Social Security Act to reauthorize demonstration authority for the disability insurance program; providing for consideration of the resolution (H. Res. 1383) commemorating the one-year anniversary of the enactment of the Working Families Tax Cuts; and for other purposes.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Portable Ultrasound Reimbursement Equity Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
National Defense Authorization Act for Fiscal Year 2027
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
Lung Cancer Screening and Prevention Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
Public Law 119 / H.R. 1968 - Full year Continuing Appropriations and Extensions Act.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
SCREENS for Cancer Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2381 -- SCREENS for Cancer Act of 2025. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.
CREATE AI Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
ROCR Value Based Program Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Women and Lung Cancer Research and Preventive Services Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Health Tech Investment Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Find It Early Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
National Defense Authorization Act for Fiscal Year 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.
SANDBOX Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
RESULTS Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Continuing Appropriations and Extensions and Other Matters Act, 2026
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Mobile Cancer Screening Act
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Death Tax Repeal Act of 2025
Client: SIEMENS MEDICAL SOLUTIONS USA, INC · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
2026 · second_quarter · Q2
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals.
H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2026 · first_quarter · Q1
Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · second_quarter · 2A
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
Issues related to medical supply chains and procurement; and Issues related to international trade
Issues related to tariffs and supply chain resilience.
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Issues related to NIH funding; and Issues related to ARPA-H Funding.
Issues related to critical minerals supply chains and production.
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · fourth_quarter · Q4
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutral payments.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · third_quarter · Q3
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled medical devices; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy, transparency and cybersecurity.
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
H.R. 4121 / S. 2256/H. Rept. 119-172/S. Rept. 119-37 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026 - issues related to FDA funding; H.R. 5304 / S. S587/H. Rept. 199-271, S. Rept. 119-55 - Labor-HHS-Education Appropriation Act, FY 2026 - issues related to HHS funding, NIH funding, and artificial intelligence; and H.R.5371 / S. 2882 - Continuing Appropriations and Extensions Act, 2026. - issues related to HHS funding, NIH funding, telehealth flexibilities, and the Hospital at Home programs.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · second_quarter · Q2
Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.
S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
SIEMENS MEDICAL SOLUTIONS USA, INC via SIEMENS MEDICAL SOLUTIONS USA, INC
2025 · first_quarter · Q1
H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Public Law 119 / H.R. 1968 - Full year Continuing Appropriations and Extensions Act.
Public Law 115-97 (Tax Cut and Jobs Act) - issues related to expiring tax provisions.
Issues related to medical supply chains and procurement; and Issues related to international trade.
Issues related to tariffs and supply chain resilience; and Issues related to tariffs on medical devices.
H.R. 3838 / S 2296 - National Defense Authorization Act, 2026 - issues related to right to repair and the BIOSECURE Act.
Issues related to NIH funding; and Issues related to ARPA-H Funding.
Issues related to critical minerals supply chains and production.
H.R. 2385 - Create AI Act of 2025; S. 2750 - SANDBOX Act; and Issues related to data privacy, transparency, and cybersecurity.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.
H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.
Issues related to medical supply chains and procurement; and Issues related to international trade
Issues related to tariffs and supply chain resilience.
H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.
Issues related to NIH funding; and Issues related to ARPA-H Funding.
Issues related to critical minerals supply chains and production.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to availability of medical isotopes; Issues related to medical supply chains and procurement; and Issues related to international trade.
Issues related to tariffs and supply chain resilience.
H.R. 2381 -- SCREENS for Cancer Act of 2025. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE